These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3816923)

  • 21. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Lundback B; Rawlinson DW; Palmer JB
    Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.
    Nelson H; Kemp J; Berger W; Corren J; Casale T; Dube L; Walton-Bowen K; LaVallee N; Stepanians M
    Ann Allergy Asthma Immunol; 2007 Aug; 99(2):178-84. PubMed ID: 17718106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework.
    Dennis SM; Sharp SJ; Vickers MR; Frost CD; Crompton GK; Barnes PJ; Lee TH
    Lancet; 2000 May; 355(9216):1675-9. PubMed ID: 10905242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Moreland TA; Struthers AD; Clark GA; McDevitt DG
    Eur J Clin Pharmacol; 1989; 37(6):567-71. PubMed ID: 2693116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-release albuterol in the treatment of 6- to 12-year-old asthmatic children.
    Skoner DP; Boltansky H; Kobayashi RH; Pearlman DS; Shapiro G; Harrison JE; Trochelmann LM; Lorber RR
    Ann Allergy Asthma Immunol; 1996 May; 76(5):462-8. PubMed ID: 8630721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Charter MK; Palmer JB; McDevitt DG
    Eur J Clin Pharmacol; 1989; 37(1):49-52. PubMed ID: 2687008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous and intermittent salbutamol tablet administration in asthmatic children.
    Lenney W; Milner AD; Hiller EJ
    Br J Dis Chest; 1979 Jul; 73(3):277-81. PubMed ID: 399859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salbutamol: tablets, inhalational powder, or nebuliser?
    Grimwood K; Johnson-Barrett JJ; Taylor B
    Br Med J (Clin Res Ed); 1981 Jan; 282(6258):105-6. PubMed ID: 6779890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily.
    Persson G; Gnosspelius Y; Anehus S
    Eur Respir J; 1988 Mar; 1(3):223-6. PubMed ID: 3384075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
    Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR
    J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 21-day double-blind study of the effect of adding sustained-release theophylline (Nuelin SA) to inhaled salbutamol in patients with asthma.
    Sahay JN; Chatterjee SS
    Br J Dis Chest; 1983 Jan; 77(1):66-70. PubMed ID: 6344899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antianginal efficacy and tolerability of controlled-release metoprolol once daily: a comparison with conventional metoprolol tablets twice daily.
    Egstrup K; Gundersen T; Härkönen R; Karlsson E; Lundgren B
    Eur J Clin Pharmacol; 1988; 33 Suppl():S45-9. PubMed ID: 3371394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
    Midgren B; Melander B; Persson G
    Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regular vs as-needed inhaled salbutamol in asthma control.
    Chapman KR; Kesten S; Szalai JP
    Lancet; 1994 Jun; 343(8910):1379-82. PubMed ID: 7910880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release salbutamol tablets versus aminophylline in the control of reversible airways obstruction.
    Higenbottam TW; Khan MA; Williams DO; Mikhail JR; Peake MD; Hughes J
    J Int Med Res; 1989; 17(5):435-41. PubMed ID: 2680678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of salbutamol inhalational powder and tablets in asthma.
    Grimwood K; Fergusson DM; Dawson KP
    Arch Dis Child; 1983 Apr; 58(4):283-5. PubMed ID: 6342544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
    Grove A; Lipworth BJ
    Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels.
    Walters EH; Cockroft A; Griffiths T; Rocchiccioli K; Davies BH
    Thorax; 1981 Aug; 36(8):625-8. PubMed ID: 7031974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.